Citadel Advisors - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 25 filers reported holding CANCER GENETICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2018$6,000
-82.4%
26,826
-19.1%
0.00%
Q3 2018$34,000
-17.1%
33,165
+218.9%
0.00%
Q2 2017$41,000
+64.0%
10,400
-43.3%
0.00%
Q4 2016$25,000
-16.7%
18,343
+22.5%
0.00%
Q2 2016$30,00014,9790.00%
Other shareholders
CANCER GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 23,937$187,0003.26%
Millrace Asset Group, Inc. 166,083$1,297,0001.43%
Sterneck Capital Management, LLC 56,950$445,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$655,0000.18%
Quality Growth Management, Inc. 23,500$184,0000.15%
TURNER INVESTMENTS LLC 99,930$781,0000.14%
ARDSLEY ADVISORY PARTNERS LP 70,700$552,0000.08%
Granite Investment Partners, LLC 110,511$863,0000.07%
DIKER MANAGEMENT LLC 23,015$180,0000.03%
Stevens First Principles Investment Advisors 1,000$8,0000.01%
View complete list of CANCER GENETICS INC shareholders